4.1 Article

A road map for leptospirosis research and health policies based on country needs in Latin America

Publisher

PAN AMER HEALTH ORGANIZATION
DOI: 10.26633/RPSP.2017.131

Keywords

Leptospirosis; health planning guidelines; health services research; Latin America

Funding

  1. Ministry of Health of Brazil (Oswaldo Cruz Institute/FIOCRUZ)
  2. Ministry of Health of Brazil (Secretariat of Health Surveillance)
  3. Ministry of Health of Brazil (Secretariat of Science and Technology)
  4. Pan American Health Organization (PAHO/WHO)
  5. GLEAN

Ask authors/readers for more resources

This report summarizes the presentations, discussions and the recommendations coming from the Oszvaldo Cruz Institute/FIOCRUZ International Workshop for Leptospirosis Research Based on Country Needs and the 5th Global Leptospirosis Environmental Action Network meeting, which was held in the city of Rio de Janeiro, Brazil, 10-12 November 2015. The event focused on health policy and worked to develop a road map as a consensus document to help guide decision-making by policymakers, funding bodies, and health care professionals. The direction that leptospirosis research should take in the coming years was emphasized, taking into account the needs of countries of Latin America, as well as experiences from other world regions, as provided by international experts. The operational concepts of One Health and translational research underlaid the discussions and the resulting recommendations. Despite the wide geographic distribution of leptospirosis and its impact in terms of incidence, morbidity, and mortality, leptospirosis is not yet considered a tool-ready disease for global initiatives. Surveillance programs need new tools and strategies for early detection, prevention, and follow-up. The major recommendations developed at the Rio meeting cover both health policy and research. The health policy recommendations should be taken into account by decisionmakers, government officials, and the Pan American Health Organization. The priorities for research, technological development, and innovation should be considered by research institutions, universities, and stakeholders.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.1
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available